Observational studySurgery today2026
Impact of the number of colorectal cancer lymph node metastases on intraperitoneal lavage cytology: a multi-institutional, prospective, observational study.
Observational study in Surgery today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWe previously identified T4, an undifferentiated histological type, and positive lymph node (LN) metastasis as risk factors for positive intraperitoneal lavage cytology (IPLC) in colorectal cancer (CRC) surgery. However, the number of LN metastases influencing IPLC positivity remains unknown. We conducted a multicenter, prospective, observational study to determine the threshold number of LN metastases associated with IPLC positivity and identify patients with CRC who should undergo IPLC.
methodsPatients with clinical stage II and III CRC who underwent tumor resection and IPLC between 2013 and 2017 were included. IPLC was performed once during laparotomy and once after tumor resection. Patients with a T4 stage, ascites, or undifferentiated types were excluded, as these factors affected IPLC. The number of LNs that influenced IPLC positivity was examined using a logistic regression analysis and the Akaike information criterion (AIC).
resultsThe IPLC positivity rate was 2.0%. The rate increased significantly in patients with ≥ 2 LN metastases, and stratification by five LN metastases yielded the lowest AIC value (156.9). The positivity rate was 8.9-fold higher in patients with ≥ 5 LN metastases than in those with < 5 metastases.
conclusionIPLC is recommended for patients with clinical stage III CRC and multiple LN metastases.
Indexed as
Identifiers
42217002What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.